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We evaluated prediagnosis predictors of breast cancer survival among 717 premenopausal breast cancer patients enrolled in a
population-based case–control study and followed for 10.4 years. Using Cox’s proportional hazards models, lifetime exercise, weight,
and height were not associated with survival. Higher body mass index (trend P¼0.21) and recent exercise activity (trend P¼0.31)
were weakly associated with longer survival.
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Evidence suggests that physical activity reduces the risk of breast
cancer (IARC, 2002), an effect first reported nearly 20 years ago
(Frisch et al, 1985). In addition, high body mass and weight gain
increase the risk of postmenopausal breast cancer (International
Agency for Research on Cancer, 2002), though a weak inverse
relationship between body mass and breast cancer risk has been
noted among premenopausal women (Ziegler, 1997; Friedenreich,
2001; Morimoto et al, 2002).
As there is currently interest in whether breast cancer risk
factors also impact on survival, we have examined these factors in
a population-based cohort of breast cancer patients.
MATERIALS AND METHODS
Subjects were breast cancer patients who participated in a
population-based case–control study among women aged 40 years
or younger (Bernstein et al, 1994). Briefly, eligible patients were
white or Hispanic women consecutively diagnosed with their first
primary in situ or invasive breast cancer from 1 July 1983 through
31 December 1989, identified by the University of Southern
California Cancer Surveillance Program (CSP), the population-
based cancer registry for Los Angeles County.
The University of Southern California institutional Review
Board (Los Angeles, CA, USA) reviewed and approved the study
that complied with all applicable federal regulations governing the
protection of human subjects. Study subjects were given a detailed
explanation of the study including the risk and benefits. All
participants provided signed informed consent to participate in
the study.
In face-to-face interviews, we obtained detailed information
about demographics and known or suspected breast cancer risk
factors, up to each patient’s reference date, defined as 12 months
before diagnosis.
We asked patients whether they had ever participated at least
twice weekly on a competitive athletic team or in dance or exercise
classes, or if they jogged or ran one mile at least twice weekly. For
those who responded ‘yes’, we recorded for each activity the age
started and stopped, the type, and the average number of hours per
week of participation. We recorded each episode when activities
were started and stopped more than once or when the amount of
time spent in the activity changed. We computed the number of
hours per week each patient participated in all recreational
exercise activities beginning with the year of each woman’s first
menstrual period and ending at the reference date.
Details were collected of height and weight at the reference date
and weight at age 18 years. Body mass index (BMI) was computed
as weight (kg) divided by the square of height (m
2) and weight gain
as the difference of weight (kg) at the reference date and weight
(kg) at age 18 years. Women with zero or negative weight gain
were defined as having a zero weight gain.
Details of stage at diagnosis (in situ, localised, regional, distant)
and lymph node involvement (number positive and number
examined) were abstracted from the records at the CSP and at the
hospital of diagnosis.
Follow-up began at interview and ended at the date of death, the
date of last follow-up, or 30 June 2000, the end of the study period,
whichever was earliest. Vital status and cause of death information
was obtained routinely from CSP records, from computerised
records of the California Death Certificate Master File and the
National Death Index, and by contacting the patients or their
relatives by telephone.
Of 969 eligible patients, we interviewed 744 (76.8%) but then
excluded 11 postmenopausal patients, 11 with unknown cancer
stage, and five deceased patients with unknown cause of death so
that a total of 717 were available for analysis of BMI, weight and
height. The first 199 patients enrolled in the case–control study
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ydid not receive the detailed assessment about lifetime exercise
habits leaving 525 patients available for the exercise analyses. Of
the 199 patients without detailed lifetime exercise data, 192 were
determined to be otherwise eligible and were included in the
analyses of body size and breast cancer survival; for these patients,
we created a separate exercise activity code.
w
2 P-values were used to assess the relationship of patient
characteristics at diagnosis with breast cancer survival. Hazard
rate ratios (HR) and 95% confidence intervals (95% Cl) were
calculated using Cox’s proportional hazards methods (Breslow and
Day, 1987). Events were deaths due to breast cancer; patients who
died from other causes or were alive at the last follow-up were
censored at the last follow-up date.
RESULTS
A total of 454 interviewed patients (63.3%) were still alive at the
date of last follow-up, with a median follow-up time of 10.4 years
(Table 1). We identified 251 breast cancer deaths and 12 deaths
due to other known causes among interviewed patients.
Nearly one-half of patients who died of breast cancer were age
35 years or younger at diagnosis compared to just over one-third
of those who were alive at the last follow-up or died from other
causes (Table 2). As expected, women who died of breast cancer
were also more likely to have had an advanced stage and lymph
node involvement at diagnosis than other patients. Almost two-
thirds of patients who died of breast cancer had regional or distant
disease at diagnosis compared to less than one-third of other
patients; figures were similar for lymph node involvement.
We observed no clear association of lifetime exercise with risk of
death from breast cancer, but higher levels of exercise in the year
before the reference date were weakly associated with a of reduced
risk of breast cancer death (Table 3). Compared to those who
reported no exercise from their first menses to the reference date,
women with the highest levels of activity did not experience a
reduced risk of dying from breast cancer. However, compared to
women who performed no exercise in the year before the reference
date, those who performed at least 5h of exercise per week, on
average, experienced a 20% reduction in risk of breast cancer
death; this was not statistically significant. We found no marked
interaction between risk of death and various combinations of
recent activity and lifetime activity levels.
We observed a nearly 25% reduced risk of death among women
in the highest quartile of BMI compared to those in the lowest
quartile of BMI, a finding that was not statistically significant
(Table 4). Women in the highest quartile of weight experienced a
statistically nonsignificant 14% reduction in risk of dying
compared with women in the lowest quartile of weight. Weight
gain from age 18 years to the reference date and height were not
associated with risk of breast cancer death.
DISCUSSION
Our findings are consistent with the only other study of physical
activity and breast cancer survival which found no relation
between risk of breast cancer death and total recreational activity
performed in the year before diagnosis (Rohan et al, 1995), similar
to our findings for lifetime exercise activity. Our median follow-up
time (10.4 years) was nearly twice that of the earlier study (5.5
years), but even with the longer follow-up time we observed no
marked association.
As we collected exercise activity data only for those who
reported that they had either competed on a sports team, had
serious and regular participation in dance, or had run or jogged
regularly for at least one mile, some women who were recorded as
having not participated in exercise activities may in fact have
participated in some activities. The inclusion of these women in
the reference category may bias the associations toward the null
value, 1.0. However, the intent of the question was to identify the
most active women, and activities among women who did not
participate in these types of activities are likely to be limited.
Our finding of a weak association of BMI with decreased risk of
death is somewhat inconsistent with the body of evidence.
Approximately two-thirds of studies have reported an increasing
risk of death with increasing BMI or weight, and the remaining
studies generally reported no association (Goodwin and Boyd,
1990; Rock and Demark-Wahnefried, 2002). The women in the
Table 1 Years of follow-up of premenopausal breast cancer patients
aged 40 years and younger.
Years of follow-up
N Median Range
All patients 717 10.4 0.3 –15.1
Alive at last follow-up 454 11.7 0.3 –15.1
Deceased due to breast cancer 251 4.5 0.6 –14.0
Deceased due to other causes
a 12 9.0 1.0 –12.6
aOther causes of death included other cancers (n¼7), coronary/cardiovascular
disease (n¼2), pulmonary disease (n¼2), and infections (n¼1).
Table 2 Characteristics of eligible breast cancer patients aged 40 years or younger at diagnosis.
Still living or died from other known causes (n¼466) Died of breast cancer (n¼251)
Characteristics at breast cancer diagnosis n % N % v
2 P
Age (years)
21–25 6 1.3 11 4.4
26–30 31 6.7 23 9.2
31–35 132 28.3 85 33.9
36–40 297 63.7 132 52.5 0.005
Stage
In Situ 68 14.6 3 1.2
Localised 255 54.7 85 33.9
Regional 139 29.8 141 56.2
Distant 4 0.9 22 8.7 o0.0001
Axillary lymph node involvement
Yes 139 29.8 156 62.1
No 323 69.3 88 35.1 o0.0001
Unknown 4 0.9 7 2.8
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and as a group had a very low median BMI prior to diagnosis. It is
possible that other factors, such as oestrogen receptor status,
account for our findings, which are also consistent with no
association.
A concern in this as in any follow-up study is loss to
follow-up. The patients who were lost to follow-up early on may
have differed from those with complete follow-up, leading to bias
in the results. However, we were able to follow-up 79% of the
patients to the end of the follow-up period and 92% to within 2
years of this point, so it is unlikely that such losses resulted
in substantial biases. Another possible limitation is that recall
of past exercise activities resulted in some misclassification,
particularly those decades before interviews. However, we
obtained activity information only from those who indicated that
they had participated in serious sports activities or dancing, which
allowed us to identify women engaged in strenuous exercise.
Although some misclassification undoubtedly occurred, it is likely
that our methods resulted in separation of the most active from the
least active cohort members. Breast cancer diagnosis may have
influenced recall of past exercise activities, but since all patients in
the cohort were interviewed after learning their diagnoses, they
should all have been similarly affected. All women in the cohort
were interviewed prior to the widespread publication of papers
indicating that exercise activity was associated with reduced breast
cancer risk.
It is unclear whether prediagnosis physical activity levels
are markers of postdiagnosis activity levels or whether
postdiagnosis physical activity influences survival. A recent
study reported 24–50% decreases in postdiagnosis compared to
prediagnosis physical activity levels of breast cancer patients
(Irwin et al, 2003), but postdiagnosis levels were assessed
within 1 year of diagnosis. We interviewed 374 of the surviving
breast cancer patients from this study in 1998–1999 as part of a
follow-up study and found that, on average, surviving women had
increased their activity levels in the years following their
diagnoses.
Overall, we observe no association of lifetime exercise with
breast cancer survival and only a weak association of higher
levels of recent exercise with breast cancer survival. In contrast, we
find a weak association of higher BMI levels with reduced risk
of breast cancer death. It remains unclear whether recent,
prediagnosis activity, and body size levels are indicators of
postdiagnosis levels. Further examination of physical activity and
body size during both pre- and postdiagnosis periods will improve
our evaluation of the impact of these factors on breast cancer
survival.
Table 3 Risk of dying from breast cancer in relation to physical activity from first menses to reference date
a and during year before the reference date,
among breast cancer patients aged 40 years or younger at diagnosis
Physical activity Censored Events HR
b 95% Cl
Average hours per week from first menses to reference date
0 117 68 1.00
0.1–0.7 71 31 0.86 0.56–1.32
0.8–1.6 63 17 0.59 0.35–1.01
1.7–3.7 66 32 0.87 0.57–1.33
3.8+ 35 25 1.30 0.81–2.09
Trend P 0.88
Average hours per week during year before reference date
0 265 143 1.00
1–4 43 15 0.85 0.50–1.45
5+ 44 15 0.78 0.45–1.34
Trend P 0.31
Hrs/wk from first menses to reference date Hrs/wk during year before reference date
0 0 117 68 1.00
0.1–3.7 0 135 63 0.86 0.61–1.21
3.8+ 0 13 12 1.34 0.72–2.47
0.1–3.7 1+ 65 17 0.61 0.36–1.04
3.8+ 1+ 22 13 1.26 0.68–2.32
Interaction P 0.07
Hrs/wk¼hours per week.
aReference date is date one year before diagnosis.
bModels include age, stage at diagnosis and BMI.
Table 4 Body size indicators
a and risk of breast cancer death among
breast cancer patients aged 40 years or younger at diagnosis
Censored Events HR
b 95% Cl
BMI (kgm
 2)
o20.4 110 65 1.00
20.4–21.9 117 64 0.79 0.56–1.12
22.0–24.8 113 66 0.89 0.63–1.26
24.9+ 118 64 0.76 0.53–1.07
Trend P 0.21
Weight (kg)
o54.1 116 57 1.00
54.1–60.9 115 81 1.10 0.78–1.54
61.0–68.1 110 54 0.87 0.60–1.26
68.2+ 125 59 0.86 0.60–1.23
Trend P 0.21
Weight gain (kg)
0 73 33 1.00
0.1–5.0 181 112 0.97 0.66–1.43
5.1–10.0 104 49 0.81 0.52–1.24
10+ 108 57 0.93 0.61–1.42
Trend P 0.53
Height (m)
o1.60 100 57 1.00
1.60–1.64 133 68 0.92 0.65–1.30
1.65–1.68 124 59 0.84 0.58–1.21
1.69+ 109 67 1.17 0.81–1.69
Trend P 0.52
aBody size indicators at reference date (1 year before diagnosis), except for weight
gain which was increase in weight from age 18 years to the reference age.
bModels
include age, stage at diagnosis and physical activity (combination of average hours per
week during the reproductive years and average hours per week during the year
before the reference date); in addition, models of weight and height are mutually
adjusted.
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